Medicines wholesale prices in Finland continued to decline in 2012, following the trend prevailing throughout the 2000s. According to the index published by Statistics Finland, medicines’ wholesale prices were down 1.1% in 2012 whereas the general price level was up 2.8% during the same period.
The decrease was particularly marked in reimbursable medicines. In the pharmaceutical contexts, “wholesale price” refers to the share accounted for by the pharmaceutical company and wholesaler in the medicine retail price, reports the trade group Pharma Industry Finland (PIF).
The price of the reimbursable medicines is pushed downwards by reimbursement decisions in force for a determined period of time, by generic substitution as well as the price competition enhanced by the reference price system. The temporary character of the reimbursements is based on legislation: the reasonable wholesale price of a novel reimbursable medicine can be adopted by the authorities for a maximum of three years while the maximum for old medicines is five years. Normally, the wholesale price decreases at every renewal of the reimbursement status.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze